Navigation Links
Emergent and DiFusion Form Strategic Partnership to Take CleanFuze™ Antimicrobial Implants to Market
Date:7/31/2013

Austin, TX (PRWEB) July 31, 2013

Emergent Technologies, Inc., a leading innovation solutions company, and DiFusion Technologies, Inc., a pioneering orthobiologics company, announced today a strategic partnership in which Emergent will assist DiFusion in the launch of its proprietary suite of CleanFuze antimicrobial orthobiologic implants.

CleanFuze implants use DiFusion’s core technology, a novel biomaterial that resists infection and forms a direct and lasting connection with bone. This material uses Metallic Ions as Therapeutic Agents (MITA’s) to effect cellular signaling and both upstream and downstream cellular metabolic processes.

According the Centers for Disease Control and Prevention, hospital infections, including surgical site infections, are the fourth largest killer in the U.S., claiming more U.S. lives than AIDS, breast cancer and traffic accidents combined.

“DiFusion’s proven biofilm inhibition technology and strong patent position are a good fit for our Partner Solutions Model,” said Thomas Harlan, Chairman and CEO of Emergent Technologies. “Utilizing our model will help DiFusion accelerate successful market acceptance and deployment of its CleanFuze technology.”

Derrick Johns, DiFusion Founder and CEO commented, “We look forward to working with Emergent and leveraging the experience and expertise the company has developed over many years of successful technology commercialization and its numerous industry partnerships.”

DiFusion will launch its CleanFuze Xiphos™ spinal implant products in the European Union later
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
2. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
3. GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
4. DuPont Realigns Leadership Team to Accelerate Integrated Science Execution, Explores Strategic Alternatives for Performance Chemicals
5. Pittsburgh Life Sciences Greenhouse Makes Strategic Adjustment To Put Laser Focus On 2013 Goals
6. Alpha Source, Inc. Hires Strategic Sourcing Manager
7. BioLife Solutions Announces Strategic Partnership with HemaCare
8. Paul Knittle Joins Wireless Analytics as Director of Strategic Accounts
9. Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc.
10. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
11. VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... processes prefer to settle into equilibriuma state of ... the realm of non-equilibrium conditions where new possibilities ... and phases, such as temperature fluctuations, freezing and ... regulate their body temperature, airplanes to fly, and ... , But even though these conditions exist naturally ...
(Date:7/24/2014)... , July 24, 2014 SRI International has ... the National Institute of Allergy and Infectious Diseases (NIAID), ... preclinical development of potential therapies for HIV infection and ... treat HIV and AIDS and the complications and opportunistic ... for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... -- Neogen Corporation (Nasdaq: NEOG ) advised market ... from new rodenticide research are premature. In its regular ... 22, 2014, Neogen,s CEO commented about several new developments ... "It was my intent Tuesday at our conference call ... type of rodenticide, but certainly not to give any ...
(Date:7/24/2014)... San Francisco, CA (PRWEB) July 24, 2014 ... entrepreneurship http://www.draperuniversity.com , is proud to announce ... entrepreneurs from 17 different countries will converge on ... Silicon Valley for an intensive, experiential program focused ... doing.” The highly selective school, currently running its ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... Inc. (Nasdaq: IDEV ) announced today the ... entitled "Once Daily Dosage Forms,of Trospium," which is ... Supernus Pharmaceuticals, Inc., The ,978 patent covers ... of trospium chloride which is indicated for the,treatment ...
... BRUNSWICK, N.J., Aug. 13 At the upcoming ... R&D Team,Leader, will present "Silicone Elastomer Gels: New ... place in Philadelphia, September 16-17., According to ... molecular,structures that provide differentiated performance features for wound ...
... - Test Cleared to Screen Donated Blood for Hepatitis ... C, on Fully and Semi-Automated Instrument Systems -, ... ) announced today that the US Food and Drug ... the,PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 2Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 3Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4
(Date:7/24/2014)... electric cars ply silent freeways, solar panels blanket rooftops ... earth, from howling winds and from the blazing desert ... is technically and economically feasible to convert California,s all-purpose ... Published in Energy , the plan shows the ... in California that could create tens of thousands of ...
(Date:7/24/2014)... has its own microbial terroir, meaning the microbial populations ... in the product, creating the final flavor according to ... Applied and Environmental Microbiology . This is the first ... sake brewery. , Many sake makers inoculate with ... Mills of the University of California, Davis, but he ...
(Date:7/24/2014)... low vision specialist at The University of Texas Health ... awarded a grant to help Harris County residents whose ... surgery. , Even with corrective lenses, many people with ... are a variety of low vision devices, such as ... vision loss. , Iyer is using the three-year, $164,645 ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4The microbes make the sake brewery 2UTHealth Dr. Bhavani Iyer awarded low vision grant 2
... Vascular and Interventional Radiology ,s impact factorthe measure of ... of article citations compared to the total number of ... journal,s quality and influence has remained consistently high over ... been enhanced recently by the increased use of new ...
... A University of Colorado School of Medicine scientist is ... could boost cognitive function in those with Down syndrome, ... potential milestone in research on this genetic condition. ... those with Down syndrome," said Alberto Costa, MD, PhD, ...
... with over half with a depth greater than 3000 ... know that the deep ocean contains a diversity of ... biological and mineral resources. Human activities are, however increasingly ... loss and, with this, the loss of many goods ...
Cached Biology News:Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 2Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 3Researcher tests promising drug on those with Down syndrome 2Man and the last great wilderness: Human impact on the deep sea 2Man and the last great wilderness: Human impact on the deep sea 3Man and the last great wilderness: Human impact on the deep sea 4
... compatible with ABI thermal cyclers, QPCR instruments ... characteristics can be sealed with heat ... Certified free of DNase, RNase and human ... Fisher Scientific, the world leader in serving ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
BD BioCoat Vented Caps for 175 cm2 Flasks...
...
Biology Products: